Chemical Structure : CHD1Li 6.11
CAS No.: 2716890-91-2
Catalog No.: PC-72745Not For Human Use, Lab Use Only.
CHD1Li 6.11 is a first in class, orally bioavailable oncogenic CHD1L inhibitor with 3.3 uM (CHD1L-cat enzyme activity).
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $198 | In stock | |
10 mg | $298 | In stock | |
25 mg | $498 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
CHD1Li 6.11 is a first in class, orally bioavailable oncogenic CHD1L inhibitor with 3.3 uM (CHD1L-cat enzyme activity).
CHD1Li 6.11 exhibits cytotoxicity with IC50 of 2.59 uM in SW620 parental tumor organoid.
CHD1Li 6.11 significantly reduced the tumor volume of CRC xenografts generated from isolated quasi mesenchymal cells (M-phenotype).
Chromodomain helicase DNA-binding protein 1 like (CHD1L) is an oncogene implicated in tumor progression, multidrug resistance, and metastasis in many types of cancer.
M.Wt | 472.405 | |
Formula | C21H22BrN5OS | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
2-(4-bromothiophen-2-yl)-N-(4-((6-methyl-2-(pyrrolidin-1-yl)pyrimidin-4-yl)amino)phenyl)acetamide |
1. Brett J Prigaro, et al. J Med Chem. 2022 Mar 10;65(5):3943-3961.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright